CHARLESTON While opioid distributors have argued there is no proof of connection between prescription painkiller use and illicit drug use, an expert in the neurobiology of addiction said, during the second day of a landmark federal trial against those distributors, that people who take prescription painkillers and illicit opioids see the same changes in their brain chemistry.
Dr. Corey Waller, an Michigan doctor with expertise in pain and substance use disorder, testified May 4 at the federal courthouse in Charleston. Lawyers for the City of Huntington and Cabell County, which sued the “Big Three” drug distributors, McKesson, AmerisourceBergen, and Cardinal Health in 2017 over their role in the drug crisis, called him to testify.
CHARLESTON – The landmark federal trial against drug distributors McKesson, AmerisourceBergen and Cardinal Health over their role in the opioid epidemic began May 3 in Charleston.
During Monday s opening arguments for the bench trial at the federal courthouse, attorneys for the plaintiffs – the City of Huntington and the Cabell County Commission – told Senior U.S. District Judge David A. Faber they plan to put forth records and testimony showing the drug distributors knew their role in the crisis and could foresee the harm.
Meanwhile, the defendants said the plaintiffs couldn’t prove a direct causal link between distribution and the crisis. Williams
CHARLESTON – The landmark federal trial against drug distributors McKesson, AmerisourceBergen and Cardinal Health over their role in the opioid epidemic began May 3 in Charleston.
During Monday s opening arguments for the bench trial at the federal courthouse, attorneys for the plaintiffs – the City of Huntington and the Cabell County Commission – told Senior U.S. District Judge David A. Faber they plan to put forth records and testimony showing the drug distributors knew their role in the crisis and could foresee the harm.
Meanwhile, the defendants said the plaintiffs couldn’t prove a direct causal link between distribution and the crisis. Williams
CHARLESTON – As the trial date looms next week, a federal judge again has denied motions for summary judgment from the defendant opioid distributors.
On April 28, Senior U.S. District Judge David A. Faber denied a motion for summary judgment regarding nuisance filed by the defendant companies AmerisourceBergen, Cardinal Health and McKesson. He also denied their motion for summary judgment on proximate causation grounds and McKesson s motion for dismissal on derivative sovereign immunity grounds. He also denied a motion filed by plaintiffs Cabell County Commission and the City of Huntington holding that Cardinal Health did not comply with its duties under the Controlled Substances Act.
CHARLESTON – As the trial date looms next week, a federal judge again has denied motions for summary judgment from the defendant opioid distributors.
On April 29, Senior U.S. District Judge David A. Faber denied a motion for summary judgment on the grounds that the plaintiff municipalities can t prove the fault element of their public nuisance claim. That motion had been filed by the defendant companies AmerisourceBergen, Cardinal Health and McKesson. The plaintiffs are the Cabell County Commission and the City of Huntington. Plaintiffs proceed in this case on a single cause of action: public nuisance, Faber wrote. This motion argues that plaintiffs claim fails on what defendants term the fault element. . Without culpable conduct meeting one of these standards, say defendants, there is no public nuisance under West Virginia law.